Crispr Therapeutics Ag (CRSP)

Change in Working Capital

-$3.70M

Quarterly · Period ending: · USD

CRSP logo

CRSP Change in Working Capital

Latest reported-$3.70M
CRSP Quarterly Change in Working Capital (-$413.00K → -$3.70M)
High-resolution chart · PNG

CRSP change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-3,698,000
-15,409,000
22,637,000
10,909,000
-16,512,000
54,848,000
-24,354,000
-40,356,000
10,490,000
210,490,000
-203,974,000
52,562,000
-79,080,000
36,907,000
-31,623,000
37,188,000
8,185,000
6,095,000
18,492,000
9,298,000
13,440,000
-14,371,000
3,453,000
-2,926,000
32,489,000
424,000
-24,455,000
-21,059,000
3,921,000
-6,837,000
3,756,000
5,689,000
2,992,000
-1,887,000
-23,221,000
2,821,000
1,413,000
-6,404,000
1,979,000
-90,000
-801,000
693,000
79,879,000
196,000
-573,000
-413,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.